The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
ALK and ROS1 gene rearrangements detected in colorectal cancer (CRC) by fluorescence in situ hybridization (FISH).
Andrew James Weickhardt
Honoraria - Pfizer
Teresa T. Nguyen
No relevant relationships to disclose
Diego D. Paskulin
No relevant relationships to disclose
Anh T. Le
No relevant relationships to disclose
Dara Aisner
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - Abbott Molecular; Boehringer Ingelheim; Pfizer
Nathan Schulte
No relevant relationships to disclose
Fiona J.M. Chionh
No relevant relationships to disclose
John Mariadason
No relevant relationships to disclose
Niall C. Tebbutt
No relevant relationships to disclose
Robert Charles Doebele
Consultant or Advisory Role - Pfizer
Honoraria - Abbott Molecular
Research Funding - Pfizer
Marileila Varella-Garcia
Honoraria - Abbott Molecular
Research Funding - Abbott Molecular